VA Northern California Health Care System, Mather Field, CA 95655, USA.
J Clin Hypertens (Greenwich). 2011 Jul;13(7):487-91. doi: 10.1111/j.1751-7176.2011.00443.x. Epub 2011 Mar 28.
A pharmacy database was used to identify patients with resistant hypertension who could then be tested for the presence of primary hyperaldosteronism. Inclusion criteria were: (1) resistant hypertension defined as uncontrolled hypertension and use of 3 antihypertensive medication classes or ≥ 4 antihypertensive classes regardless of blood pressure; (2) low or normal potassium levels (≤ 4.9 mEq/L); and (3) continuous health care from October 1, 2008, to February 28, 2009. Exclusion criteria were: (1) past or current use of an aldosterone antagonist, or (2) a medication possession ratio (adherence) <80% for any antihypertensive drug. Hyperaldosteronism was classified as an aldosterone/renin ratio (ARR) ≥ 30. Using the computer, 746 patients were identified who met criteria. After manual chart review to verify inclusion and exclusion criteria, 333 patients remained. Of 184 individuals in whom an ARR was obtained, 39 (21.2%) had a ratio of ≥ 30. A computer database is useful to identify patients with resistant hypertension and those who may have primary aldosteronism.
使用药房数据库来识别患有耐药性高血压的患者,然后对这些患者进行原发性醛固酮增多症的检测。纳入标准为:(1)耐药性高血压定义为未控制的高血压和使用 3 种降压药物类别或≥ 4 种降压药物类别,无论血压如何;(2)低钾或正常钾水平(≤ 4.9 mEq/L);(3)从 2008 年 10 月 1 日至 2009 年 2 月 28 日期间持续接受医疗保健。排除标准为:(1)过去或目前使用醛固酮拮抗剂,或(2)任何降压药物的用药维持率(依从性)<80%。醛固酮增多症被定义为醛固酮/肾素比值(ARR)≥ 30。通过计算机,共确定了 746 名符合条件的患者。在进行手动图表审查以验证纳入和排除标准后,仍有 333 名患者符合条件。在获得 ARR 的 184 名个体中,有 39 名(21.2%)的比值≥ 30。计算机数据库可用于识别患有耐药性高血压的患者和可能患有原发性醛固酮增多症的患者。